Applicability of next generation sequencing technology in microsatellite instability testing

Genes

Volumn 6, Issue 1, 2015, Pages 46-59

  Gan, Chun ^a,b   Love, Clare ^a   Beshay, Victoria ^a   Macrae, Finlay ^a,b   Fox, Stephen ^a   Waring, Paul ^a   Taylor, Graham ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

Colorectal cancer; Microsatellite instability; MiSeq; Next generation sequencing

Indexed keywords

AMPLICON; ARTICLE; COLORECTAL TUMOR; CONTROLLED STUDY; GENE LOCUS; GENE SEQUENCE; GENETIC MARKER; GENETIC SCREENING; GENETIC VARIABILITY; MICROSATELLITE INSTABILITY; MULTIPLEX POLYMERASE CHAIN REACTION; NEXT GENERATION SEQUENCING;

EID: 84924290047     PISSN: None     EISSN: 20734425     Source Type: Journal    
DOI: 10.3390/genes6010046     Document Type: Article

References (27)

1. Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group. Recommendations from the EGAPP Working Group: Genetic testing strategies in newly diagnosed individuals with colorectal cancer aimed at reducing morbidity and mortality from Lynch syndrome in relatives. Genet. Med. 2009, 11, 35–41.
2. Woerner, S.M.; Kloor, M.; Mueller, A.; Rueschoff, J.; Friedrichs, N.; Buettner, R.; Buzello, M.; Kienle, P.; Knaebel, H.-P.; Kunstmann, E.; et al. Microsatellite instability of selective target genes in HNPCC-associated colon adenomas. Oncogene 2005, 24, 2523–2535.
3. Boland, C.R.; Thibodeau, S.N.; Hamilton, S.R.; Sidransky, D.; Eshleman, J.R.; Burt, R.W.; Meltzer, S.J.; Rodriguez-Bigas, M.A.; Fodde, R.; Ranzani, G.N.; et al. A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: Development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res. 1998, 58, 5248–5257.
4. Cicek, M.S.; Lindor, N.M.; Gallinger, S.; Bapat, B.; Hopper, J.L.; Jenkins, M.A.; Young, J.; Buchanan, D.; Walsh, M.D.; le Marchand, L.; et al. Quality assessment and correlation of microsatellite instability and immunohistochemical markers among population- and clinic-based colorectal tumors results from the Colon Cancer Family Registry. J. Mol. Diagn. 2011, 13, 27–281.
5. Deschoolmeester, V.; Baay, M.; Wuyts, W.; van Marck, E.; van Damme, N.; Vermeulen, P.; Lukaszuk, K.; Lardon, F.; Vermorken, J.B. Detection of microsatellite instability in colorectal cancer using an alternative multiplex assay of quasi-monomorphic mononucleotide markers. J. Mol. Diagn. 2008, 10, 154–159.
6. Pastrello, C.; Baglioni, S.; Tibiletti, M.G.; Papi, L.; Fornasarig, M.; Morabito, A.; Agostini, M.; Genuardi, M.; Viel, A. Stability of BAT26 in tumours of hereditary nonpolyposis colorectal cancer patients with MSH2 intragenic deletion. Eur. J. Hum. Genet. 2006, 14, 63–68.
7. Schofield, L.; Watson, N.; Grieu, F.; Li, W.Q.; Zeps, N.; Harvey, J.; Stewart, C.; Abdo, M.; Goldblatt, J.; Iacopetta, B. Population-based detection of Lynch syndrome in young colorectal cancer patients using microsatellite instability as the initial test. Int. J. Cancer 2009, 124, 1097–1102.
8. Ribic, C.M.; Sargent, D.J.; Moore, M.J.; Thibodeau, S.N.; French, A.J.; Goldberg, R.; Hamilton, S.R.; Laurent-Puig, P.; Gryfe, R.; Shepherd, L.E.; et al. Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer. N. Engl. J. Med. 2003, 349, 247.
9. Carethers, J.M.; Smith, E.J.; Behling, C.A.; Nguyen, L.; Tajima, A.; Doctolero, R.T.; Cabrera, B.L.; Goel, A.; Arnold, C.A.; Miyai, K.; et al. Use of 5-fluorouracil and survival in patients with microsatellite-unstable colorectal cancer. Gastroenterology 2004, 126, 394.
10. Sargent, D.J.; Marsoni, S.; Monges, G.; Thibodeau, S.N.; Labianca, R.; Hamilton, S.R.; French, A.J.; Kabat, B.; Foster, N.R.; Torri, V.; et al. Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer. J. Clin. Oncol. 2010, 28, 3219.
11. Zhang, X.; Li, J. Era of universal testing of microsatellite instability in colorectal cancer. World J. Gastrointest Oncol. 2013, 5, 12–19.
12. Burt, R.W.; Cannon, J.A.; David, D.S.; Early, D.S.; Ford, J.M.; Giardiello, F.M.; Halverson, A.L.; Hamilton, S.R.; Hampel, H.; Ismail, M.K.; et al. Colorectal cancer screening. J. Natl. Compr. Canc. Netw. 2013, 11, 1538–1575.
13. Liu, L.; Li, Y.; Li, S.; Ni, H.; He, Y.; Pong, R.; Lin, P.; Lu, L.H.; Law, M. Comparison of next-generation sequencing systems. J. Biomed. Biotechnol. 2012, Article ID 251364.
14. Mciver, L.J.; Fonville, N.C.; Karunasena, E.; Garner, H.R. Microsatellite genotyping reveals a signature in breast cancer exomes. Breast Cancer Res. Treat 2014, 145, 791–798.
15. Salipante, S.J.; Scroggins, S.M.; Hampel, H.L.; Turner, E.H.; Pritchard, C.C. Microsatellite instability detection by next generation sequening. Clin. Chem. 2014, 60, 1192–1199.
16. Kim, T.M.; Laird, P.W.; Park, P.J. The landscape of microsatellite instability in colorectal and endometrial cancer genomes. Cell 2013, 155, 858–868.
17. Lu, Y.H.; Soong, T.D.; Elemento, O. A novel approach for characterizing microsatellite instability in cancer cells. PLOS ONE 2013, 8, e63056.
18. Yoon, K.; Lee, S.; Han, T.; Moon, S.Y.; Yun, M.S.; Kong, S.; Jho, S.; Choe, J.; Yu, J.; Lee, H.; et al. Comprehensive genome- and transcriptome-wide analyses of mutations associated with microsatellite instability in Korean gastric cancers. Genome Res. 2013, 23, 1109–1117.
19. Thomas, R.K.; Nickerson, E.; Simons, J.F.; Janne, P.A.; Tengs, T.; Yuza, Y.; Garraway, L.A.; LaFramboise, T.; Lee, J.C.; Shah, K.; et al. Sensitive mutation de-tection in heterogeneous cancer specimens by massively parallel picoliter reactor sequencing. Nat. Med. 2006, 12, 852–855.
20. Fox, S.; Beshay, V. Peter MacCallum Cancer Institute: East Melbourne, Victoria, Australia; Unpublished data, 2010.
21. Waring, P.; Cliff, S. University of Melbourne, Parkville, Victoria, Australia. Unpublished data, 2013.
22. Luthra, R.; Patel, K.P.; Reddy, N.G.; Haghshenas, V.; Routbort, M.J.; Harmon, M.A.; Barkoh, B.A.; Kanagal-Shamanna, R.; Ravandi, F.; Cortes, J.E.; et al. Next-generation sequencing-based multigene mutational screening for acute myeloid leukemia using MiSeq: Applicability for diagnostics and disease monitoring. Haematologica 2014, 99, 465–473.
23. Li, X.; Buckton, A.J.; Wilkinson, S.L.; John, S.; Walsh, R.; Novotny, T.; Valaskova, I.; Gupta, M.; Game, L.; Barton, P.J.; et al. Towards clinical molecular diagnosis of inherited cardiac conditions: A comparison of bench-top genome DNA sequencers. PLOS ONE 2013, 8, e67744.
24. Kanagal-Shamanna, R.; Portier, B.P.; Singh, R.R.; Routbort, M.J.; Aldape, K.D.; Handal, B.A.; Rahimi, H.; Reddy, N.G.; Barkoh, B.A.; Mishra, B.M.; et al. Next-generation sequencing-based multi-gene mutation profiling of solid tumors using fine needle aspiration samples: Promises and challenges for routine clinical diagnostics. Mod. Pathol. 2014, 27, 314–327.
25. Zhou, X.P.; Hoang, J.M.; Li, Y.J.; Seruca, R.; Carneiro, F.; Sobrinho-Simoes, M.; Lothe, R.A.; Gleeson, C.M.; Russell, S.E.; Muzeau, F.; et al. Determination of the replication error phenotype in human tumors without the requirement for matching normal DNA by analysis of mononucleotide repeat microsatellites. Genes Chromosomes Cancer 1998, 21, 101–107.
26. Brennetot, C.; Buhard, O.; Jourdan, F.; Flejou, J.; Duval, A.; Hamelin, R. Mononucleotide repeats BAT-26 and BAT-25 accurately detect MSI-H tumors and predict tumor content: implications for population screening. Int. J. Cancer 2005, 113, 446–450.
27. Mead, L.J.; Jenkins, M.A.; Young, J.; Royce, S.G.; Smith, L.; St John, D.J.; Macrae, F.; Giles, G.G.; Hopper, J.L.; Southey, M.C. Microsatellite instability markers for identifying early-onset colorectal cancers caused by germ-line mutations in DNA mismatch repair genes. Clin. Cancer Res. 2007, 13, 2865–2869.